» Articles » PMID: 18176604

Cancers Take Their Toll--the Function and Regulation of Toll-like Receptors in Cancer Cells

Overview
Journal Oncogene
Date 2008 Jan 8
PMID 18176604
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer could be deemed as an abnormal and uncontrolled tissue repair process. Therefore, it would not be surprising that factors that function in the tissue repair process, such as cytokines, chemokines, growth factors and Toll-like receptor (TLR) ligands, as well as growth signals for compensatory proliferation, would also be key factors in regulating and enhancing cancer progression. The TLR pathways, which play a critical role in tissue repair, are also key regulators in cancer progression as well as chemoresistance. TLRs serve as cell surface sensors that can initiate pathways leading to proliferation and chemoresistance; as well as mediators that are able to regulate the infiltrating immune cells to provide further support for cancer progression.

Citing Articles

Research advancements in nanoparticles and cell-based drug delivery systems for the targeted killing of cancer cells.

Abdessalem M, Adham S Oncol Res. 2024; 33(1):27-44.

PMID: 39735681 PMC: 11671623. DOI: 10.32604/or.2024.056955.


Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets.

Pessino G, Scotti C, Maggi M, Immuno-Hub Consortium Cancers (Basel). 2024; 16(5).

PMID: 38473265 PMC: 10931414. DOI: 10.3390/cancers16050901.


promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation.

Martin-Gallausiaux C, Salesse L, Garcia-Weber D, Marinelli L, Beguet-Crespel F, Brochard V Gut Microbes. 2023; 16(1):2295384.

PMID: 38126163 PMC: 10761154. DOI: 10.1080/19490976.2023.2295384.


Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes.

Liu C, Peng H, Siao A, Tsuei Y, Lin Y, Shiah S Exp Biol Med (Maywood). 2023; 248(20):1695-1707.

PMID: 37646261 PMC: 10792425. DOI: 10.1177/15353702231191206.


Aspirin increases chemosensitivity of colorectal cancer cells and inhibits the expression of toll-like receptor 4.

Ying J, Zhou H, Wang Z, You Q, Chen J, Lu H Cancer Cell Int. 2023; 23(1):6.

PMID: 36647071 PMC: 9843993. DOI: 10.1186/s12935-023-02847-4.